- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | AstraZeneca reports positive phase 3 data for tozorakimab in COPD | ||
| Di | Merck's RSV antibody for infants approved by European Commission | ||
| Di | AI-powered launches on a limited budget: a playbook for emerging biopharma | ||
| Mo | Eli Lilly to acquire Kelonia Therapeutics in deal worth up to $7bn | ||
| Mo | MHRA authorises Biogen's higher-dose Spinraza for SMA treatment | ||
| Mo | Beyond the injection: why the real work of weight loss starts where the drug leaves off | ||
| Fr | J&J's Icotyde approved by US FDA for plaque psoriasis | ||
| Fr | Envision appoints Darren Coleman as Executive VP, Chief Information Officer | ||
| Do | AL-S Pharma release new data from AP-101 phase 2 trial for ALS | ||
| Do | Envision appoints Jay Ferro as President, Technology and Chief Product Officer | ||
| 22.04. | Grifols share results identifying early signs of Parkinson's disease | ||
| 22.04. | Richmond Pharmacology appoints John Hotti as Chief Technology Officer | ||
| 21.04. | Shionogi starts phase 2 clinical trial for Pompe Disease | ||
| 21.04. | Clasado appoints Sebastian Nummelin as new APAC Regional Director | ||
| 20.04. | Astellas' application to EMA validated for treatment of muscle-invasive bladder cancer | ||
| 20.04. | CNX Therapeutics appoints David Flint as Chief Corporate Development Officer | ||
| 17.04. | Potential US-Iran peace deal to redraw market winners and losers | ||
| 17.04. | Sumitomo Pharma's stem cell therapy for Parkinson's given limited approval in Japan | ||
| 17.04. | Allergan Aesthetics launches Skin Quality Index for aesthetic consultations | ||
| 16.04. | AC Immune amends agreement with Lilly to develop potential Alzheimer's treatment | ||
| 16.04. | Bowel Research UK appoints Kathryn Pretzel-Shiels as CEO | ||
| 15.04. | EMA's PRIME scheme launches three major new features | ||
| 14.04. | Annovis partners with NeuroRPM on new AI platform to track Parkinson's symptoms | ||
| 14.04. | START partners with Trialing to expand patient access to oncology clinical trials across Europe | ||
| 13.04. | Bristol Myers Squibb evolves and expands multiple myeloma programme |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.